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Abstract
Background The aim of this study was to evaluate the asso-
ciation between blood pressure (BP) and urinary
angiotensinogen excretion (uAGT) and renal sodium excre-
tion (uNa) in children with type 1 diabetes mellitus (DM1).
Methods The study group consisted of 52 children with DM1
(28 males and 24 females) with albumin/creatinine ratio
(ACR) below 30 mg/g and glomerular filtration rate (eGFR)
above 90 ml/min/1.73 m2. BP was assessed by 24-h ambula-
tory blood pressure monitoring (ABPM).
Results The patients showed significantly increased uAGT
values with respect to controls (median 0.00 and range 1.76
vs. 0.00 and 0.00 ng/mg, respectively). The significant in-
crease of uAGT was observed even in prehypertensive pa-
tients. uAGT concentrations showed positive correlation with
systolic and diastolic 24-h BP and with mean arterial pressure
(MAP) (r=0.594). uNa values were negatively correlated with
BP parameters, uAGT, ACR and eGFR.
Conclusions An increase in uAGT precedes hypertension
(HTN) in normoalbuminuric children with DM1 and may be
considered as a new marker of HTN. Decreased sodium
excretion seems to be involved in the development of HTN
and early renal injury. Both uAGT and uNa are associated
with BP in normoalbuminuric diabetic children.
Keywords Hypertension . Diabetic kidney disease .
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Introduction
Diabetic kidney disease (DKD) is a leading cause of chronic
kidney disease, with a high risk of end-stage renal disease [1,
2]. DKD, previously known as diabetic nephropathy, is de-
fined as persistent proteinuria greater than 500 mg/24 h or
albuminuria greater than 300 mg/24 h, and is usually associ-
ated with hypertension (HTN) and decreased glomerular fil-
tration rate [3]. The first clinical sign of incipient nephropathy
secondary to diabetes is microalbuminuria [4, 5]. However,
some patients are able to develop DKD without preceding
microalbuminuria or can reduce renal function even during
the microalbuminuria stage [6, 7]. Therefore, a more sensitive
and specific marker for incipient DKD is needed. In clinical
and experimental trials, it has been shown that activation of
the intrarenal renin-angiotensin system (RAS) has a potential
role in the mechanism and progression of DKD [8–10]. The
excretion of urinary angiotensinogen could be a potential
biomarker of intrarenal RAS status in clinical and experimen-
tal type 1 diabetes [11–13]. Angiotensinogen (AGT) is the
only known substrate for renin, which is the rate-limiting
enzyme of the RAS [14]. AGT is synthesized in the liver
and proximal tubule. The origin of urinary AGT (uAGT) is
not fully known. Some authors conclude that uAGT derives
only from the kidneys and reflects intrarenal activation of the
RAS [15–17]. However, Matsusaka et al. concluded that in
non-diabetic mice, the primary source of renal AGT protein
and angiotensin II is liver AGT, which is filtered by the
glomeruli and reabsorbed by the proximal tubule through
megalin-intact cells [18]. Disruption of the filtration barrier
in a transgenic mouse model increased both tubular and uri-
nary AGTwithout any increase in renal renin activity.
On the other hand, it has been shown that in diabetic rats,
overexpression of AGT in the proximal tubule may result
from hyperglycemia and may lead to tubular apoptosis,
tubulointerstitial fibrosis and HTN [19, 20]. HTN is a risk
J. Soltysiak (*) :D. Ostalska-Nowicka :
M. Lewandowska-Stachowiak :K. Lipkowska : J. Zachwieja
Department of Pediatric Cardiology and Nephrology,
Poznan University of Medical Sciences, 27/33 Szpitalna St.,
60-572 Poznan, Poland
e-mail: jsoltysiak1@gmail.com
B. Skowronska : P. Fichna :W. Stankiewicz
Department of Pediatric Diabetes and Obesity, Poznan University of
Medical Sciences, Poznan, Poland
Pediatr Nephrol (2014) 29:2373–2378
DOI 10.1007/s00467-014-2861-0
factor and may accelerate the progression of microvascular
and macrovascular complications including DKD [21].
Identification of individuals at risk of developing HTN and
renal disease is of cardinal importance to retard the progres-
sion of renal injury in diabetes [21]. AGT is important not only
in the control of arterial pressure, but also in the control of
renal sodium excretion [16]. Enhanced tubular sodium reab-
sorption is stimulated by intrarenal angiotensin II as indicated
by proximal tubular AGT, and may contribute to the genesis
of HTN [16, 22–24].
In the present study, we investigated uAGT and urinary
sodium excretion (uNa) in relation to BP in children with type
1 diabetes mellitus (DM1) not presenting diabetic kidney
disease; that is, with normoalbuminuria and glomerular filtra-
tion rate above 90 ml/min/1.73 m2.
Material and methods
Patient and control groups
The study group consisted of 52 children with DM1 (28 males
and 24 females) with a mean age of 14.39±2.49 years. The
average time of treatment was 7.86±14.76 years. Children
with infections, inflammatory states, proteinuria, glycosuria or
any abnormal urine analysis or renal impairment were exclud-
ed to avoid potential confounding factors. None of the patients
was overweight or obese. We used relative body mass index
(RBMI) to estimate body fat content. RBMI was defined as
actual BMI divided by ideal (50th percentile) BMI for specific
age and sex. To avoid the impact of very low birth weight
(VLBW) on uAGT concentration, children with birth weight
below 1,500 g were excluded from the study [25]. All patients
had an estimated glomerular filtration rate (eGFR) above
90 ml/min/1.73 m2, according to the Filler formula [26] and
normal urinary albumin excretion (< 30 mg/g) defined by the
albumin/creatinine ratio (ACR). Glomerular hyperfiltration
was recognized above 135 ml/min/1.73 m2, calculated as the
sum of mean value plus two standard deviations (SD) [27].
Screening for microalbuminuria (MA) was performed three
times in first early morning urine sample for 3 months. The
urine sample collected on the same morning as the blood
sample was chosen for statistical analysis. Long-term glyce-
mic control was based on hemoglobin A1c (HbA1c) levels
[28]. To better assess glycemic control, patients were
categorised by HbA1c values into; a group with ideal glyce-
mic control (< 6.5 % HbA1c), optimal (< 7.5 % HbA1c),
suboptimal (7.5–9.0 % HbA1c) and poor (> 9.0 % HbA1c)
[28]. None of the patients received RAS blockades. All sub-
jects continued on free sodium intake and no medication other
than insulin was allowed.
The control group consisted of 20 healthy, age-matched
and gender-matched adolescents hospitalized due to suspected
urinary tract defects (congenital abnormalities). Patients with
congenital abnormalities, as well as infections, kidney dis-
eases, diabetes mellitus and HTN, were excluded based on
clinical examination, laboratory tests and abdominal ultraso-
nography. Urine and blood samples were collected on the
same morning and frozen immediately.
The study protocol was approved by the local Ethics
Committee, and every participant and his/her parents/legal
guardians gave fully informed consent to take part in the
study. The study was conducted according to the principles
expressed in the Second Declaration of Helsinki.
24-hour ambulatory blood pressure monitoring (ABPM)
ABPM was performed using an oscillometric device
(SpaceLabs 90217) approved by the European Society of
Hypertension [29]. The monitor was programmed to measure
BP every 20 min during the day (7 am–10 pm), and every
30 min during the night (10 pm–7 am). The parents and
children were instructed to keep a diary of daily activities
during the ABPM measurement. However, in order to com-
pare with the normative values for ABPM, we defined the
daytime period as 8 am to 8 pm, and the nighttime period as
12 pm to 6 am [30, 31]. The cuff size was determined by
measurement of the mid-arm circumference, and was approx-
imately 40 % of the arm circumference [26]. The cuff was
placed on the non-dominant arm. The patients were instructed
to avoid vigorous physical exercise during ABPM measure-
ment, but to follow their usual daily activities. A minimum of
40 recordings was required to consider the ABPM as valid
[30]. The following ABPM parameters were analyzed: mean
arterial pressure (MAP), systolic/diastolic BP over 24 h, dur-
ing daytime and nighttime. The diurnal BP rhythmicity was
assessed by the ratio between the day and night (D/N) BP for
MAP. A D/N ratio of ≥ 1.1 was considered as normal dipping
status, whereas non-dipping status was defined as a D/N ratio
<1.1.
Patients were considered as hypertensive if their MAP,
systolic and diastolic BP were above the 95th percentile,
regardless of BP load and dipping/non-dipping status.
Prehypertensive children (preHTN) showed BP below the
95th percentile, while normal BP (nBP) was recognized as
below the 90th percentile.
Measurements
AGT was measured in urine using a commercially available
enzyme-linked immunosorbent assay (ELISA) kit in accor-
dance with the manufacturer’s instructions (Uscn Life Science
Inc., Houston, USA). Inter-assay and intra-assay coefficient
variations were 5–10 %. Urine samples were collected in the
morning and immediately stored at −70 °C. All urine speci-
mens were used within 3 months after collection. To avoid
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differences in spot urine, uAGT was corrected for urinary
creatinine. uNa and common biochemical parameters were
determined in the clinical laboratory of the Poznan Medical
University Hospital. Urinary albumin and creatinine concen-
trations were measured using an automated analyzer (Bayer).
Statistical analysis
Results of the studied biomarkers were non-normally distrib-
uted and nonparametric testing was used to compare all con-
centrations between the groups (Mann–Whitney test). Values
that followed a non-normal distribution are expressed as mean
± standard deviation (SD). The relationship between two
variables was assessed by Spearman’s rank correlation coef-
ficient. The level of statistical significance was < 0.05.
Results
The demographic and clinical data of the study group and
controls are given in Table 1. Children with DM1 showed
increased uAGT values with respect to controls (median 0.00
and range 1.76 vs 0.00 and 0.00 ng/mg). ACR, eGFR and uNa
levels did not differ between the study groups. The compari-
son of children with normal BP, preHTN and HTN revealed a
significant increase of uAGT in preHTN patients, as well as in
HTN, when compared to controls (Table 2, Fig. 1). Changes
of ACR, eGFR and uNa levels were not significant (Table 2).
uAGT levels showed a positive correlation with BP values,
both systolic and diastolic 24-h BP, with the strongest rela-
tionship with MAP (r=0.594). The D/N ratio demonstrated
negative correlation with uAGT values (r=−0.279). No
correlations between uAGT and ACR, eGFR or HbA1c, as
well as diabetes duration were found. There was no relation-
ship between uAGT and HbA1c in different subgroups, in-
cluding those with different diabetic control. In contrast,
ACR, eGFR, and HbA1c, as well as uAGT, were negatively
correlated with uNa (Table 3). Moreover, uNa demonstrated a
negative relationship with BP parameters, especially systolic
BP and D/N ratio.
There was no significant correlation between BP parame-
ters, that is, between systolic BP, diastolic BP, D/N ratio and
eGFR, ACR.
Thirteen children (25 %) presented glomerular
hyperfiltration.
Receiver operating characteristic (ROC) analysis of uAGT
ROC analysis was performed in order to define the diagnostic
profile of uAGT in identifying hypertensive patients (above
95th percentile) among all diabetic children with normal al-
bumin excretion. To this end, uAGT showed a good diagnos-
tic profile, describing an AUC of 0.833 (CI: 0.704–0.922)
with a best cutoff value of > 0 ng/mg (sensitivity 94.12 %;
specificity 82.86 %; see Table 4; Fig. 1).
Discussion
The present study shows that in normoalbuminuric children
with DM1 and with glomerular filtration above 90 ml/min/
1.73 m2, there is a significant increase in the level of uAGT.
This suggests that uAGTmay serve as an early marker of renal
involvement in patients with diabetes, and indicates that early
activation of RAS may precede all other abnormalities typi-
cally required to diagnose DKD. Furthermore, uAGT corre-
lated positively with BP. Children with normal BP—that is,
below the 90th percentile—did not show elevated uAGT. The
significant increase in uAGT was observed even in
prehypertensive patients. These results indicate the potential
association of uAGT with HTN in diabetic children, with an
additional predictive value to detect prehypertensive children.
Moreover, the ROC analysis revealed a good diagnostic pro-
file of uAGT in identifying hypertensive patients, and showed
that uAGT may be considered as a new marker of HTN in
DM1. The association of 24-h systolic and diastolic BP with
uAGT in diabetic children has not been previously studied.
However, a positive relationship between uAGT and BP has
been demonstrated in many reports in hypertensive, but non-
diabetic patients, including adolescents [16, 20, 23, 32–34]. It
has been shown that increased uAGT, through increased an-
giotensin II levels, leads to salt-sensitive HTN via salt reten-
tion [16, 20, 22, 23, 32, 34]. In this study, the inverse corre-
lation between uAGT and uNa was demonstrated. This might
Table 1 The demographic and clinical data of the study group and
controls
Parameters Diabetes, n=52 Controls, n=20 p
Median Range Median Range
uAGT (ng/mg) 0.00 1.76 0.00 0.00 0.015
Age (yr) 14.56 8.73 12.08 10.61 NS
RBMI (%) 104.7 15.96 101.81 16.66 NS
eGFR (ml/min/1.73 m2) 111.44 140.06 101.27 83.99 NS
HbA1c (%) 7.95 9.00 5.45 0.80 <0.001
ACR (mg/g) 8.09 24.46 6.25 7.61 NS
uNa (mmol/l) 100.95 235.10 102.80 141.70 NS
sNa (mmol/l) 140.50 14.00 139.50 6.00 NS
FENa 0.33 1.06 0.25 0.48 NS
p confidence level, NS non-significant, na not applicable, SD standard
deviation, uAGT urinary AGT corrected for urinary creatinine (ng/mg),
uNa urinary sodium, sNa serum sodium, RBMI relative body mass index,
eGFR estimated glomerular filtration rate, ACR albumin/creatinine ratio
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suggest that enhanced sodium reabsorption is caused by ele-
vated angiotensin II, reflected by the increased level of uAGT.
However, in hypertensive, non-diabetic patients, it was shown
that uAGT excretion was higher, with greater uNa resulting
from higher sodium intake [22, 23, 32]. The authors conclud-
ed that increased dietary sodium stimulates the expression of
AGT in the proximal tubule and is associated with clinical and
ambulatory HTN [20, 32, 35, 36].
In diabetes, elevated uAGT and enhanced intrarenal RAS
activity may be caused by hyperglycemia without being af-
fected by sodium intake [9, 10, 19]. This is a potential mech-
anism for the development of HTN in diabetic patients.
However, in the early stages of diabetes type 1, the influence
of enhanced sodium reabsorption stimulated only by hyper-
glycemia seems to play an important role. The increase in
glucose and sodium reabsorption through enhanced expres-
sion of the Na/glucose co-transporter (SGLT) in the proximal
tubule decreases uNa. Reduced uNa concentration in distal
tubular fluid at the macula densa enhances glomerular filtra-
tion through the tubuloglomerular feedback (TGF) system
[37, 38]. This is a typical early signal of renal involvement
in diabetes. In the present study, 25 % of diabetic children
Table 2 The comparison of diabetic children to controls by blood pressure groups
Parameters nBP; n=28 preHA; n=7 HA; n=17 Controls p* p** p***
Median Range Median Range Median Range Median Range
uAGT (ng/mg) 0.00 1.76 0.04 0.88 0.02 0.35 0.00 0.00 NS 0.009 < 0.001
eGFR (ml/min/1.73 m2) 105.77 83.52 105.77 45.54 122.04 134.22 101.27 83.99 NS NS NS
ACR (mg/g) 6.12 23.79 7.92 20.38 12.81 24.28 6.25 7.61 NS NS NS
uNa (mmol/l) 112.00 214.00 91.50 162.10 83.15 143.50 102.80 141.70 NS NS NS
sNa (mmol/l) 141.00 14.00 138.00 8.00 140.00 10.00 139.50 6.00 NS NS NS
FENa 0.40 0.87 0.51 0.63 0.22 0.58 0.25 0.48 NS NS NS
p*—confidence level between nBP and Controls; p**—confidence level between preHA and Controls
p***—confidence level between HA and Controls
nBP normal blood pressure, preHA prehypertensive, HA hypertensive, uNa urinary sodium, sNa serum sodium; SD standard deviation, uAGT urinary
AGT corrected for urinary creatinine (ng/mg), eGFR estimated glomerular filtration rate, ACR albumin/creatinine ratio
Fig. 1 Receiver operating characteristic (ROC) curves of uAGT consider-
ing the presence of hypertension (≥ 95 pc) in normoalbuminuric children
with diabetes as status variable. The AUC for uAGTwas 0.833 (CI: 0.704–
0.922). The best cutoff value for the identification of hypertension in diabetes
was found to be above 0 ng/mg, with a sensibility of 94.12 (CI: 71.3–99.9)
and a specificity of 82.86 (CI: 68.4–93.4), uAGT urinary angiotensin
Table 3 The correlations of uAGT and uNa values with blood pressure
and clinical parameters in the diabetic group







D/N ratio r=−0.279 r=0.419
p=0.042 p=0.002
Diabetes duration (yr) NS r=−0.401
p=0.003
eGFR (ml/min/1.73 m2) NS r=−0.338
p=0.011
HbA1c (%) NS r=−0.334
p=0.009
ACR (mg/g) NS r=−0.329
p=0.008
uNa (mmol/l) r=−0.379 na
p=0.009
sNa (mmol/l) NS NS
FENa r=−0.337 na
p=0.006
p confidence level, NS non-significant, na not applicable, D/N ratio the
ratio between day and night (D/N) BP for MAP, uAGT urinary AGT
corrected for urinary creatinine (ng/mg), uNa urinary sodium, sNa serum
sodium, ACR albumin/creatinine ratio, AGT angiotensin
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presented glomerular hyperfiltration, and this may result
from the increase in glucose and sodium reabsorption
through enhanced expression on SGLT in proximal
tubules.
Taken together, arterial HTN in DM1 might be caused by
increased sodium retention resulting from two independent
mechanisms: increased expression of the Na/glucose co-
transporter, and increased angiotensin II levels. Might this,
therefore, influence the antihypertensive policy in patients
with DM1 using intrarenal RAS blockers or SGLT blockers?
The question needs further investigation. However, a recent
large-scale clinical study has reported that RAS inhibitors
delay renal impairment caused by diabetic nephropathy, and
in the present study, RAS blockers were administered to
hypertensive patients [39].
It should be emphasized that in this study, uNa levels
within the whole study group did not differ from the controls.
Similar observations have been reported by other au-
thors, however for adult populations with DM1 [40]. In
our children with early diabetic complications, decreased
uNa concentration was observed. Children with HTN, as
well as those with higher ACR, eGFR and HbA1c
values, and longer duration of the disease showed lower
levels of uNa. In the literature there is little information
concerning the relationship between sodium excretion,
albuminuria and renal damage, and these observations
require further evaluation.
Interestingly, there was no significant correlation between
uAGT and ACR as well as eGFR. Positive correlations be-
tween uAGT, ACR and proteinuria have been shown in other
studies, but in adult hypertensive patients without diabetes
[23]. In type 1 diabetes, these relations were not demonstrated
and it was concluded that elevated uAGT in prealbuminuric
phase patients is not simply a nonspecific consequence of
proteinuria [11, 12]. In non-diabetic mice, it has been shown
that filtered AGTwas reabsorbed by the proximal tubule [18];
thus, increased levels of uAGT in diabetic children might also
result from lack of AGT reabsorption by injured proximal
tubules. This may suggest that increased uAGT is an early
sign of kidney damage in DM1, before the onset of
microalbuminuria.
This study has some limitations. Firstly, it is a relatively
small, but homogeneous group. Secondly, the impact of sodi-
um intake was not studied; however, all subjects continued on
free sodium intake. Next, intrarenal and serum RAS activity
was not measured, but in many previous reports it was clearly
stated that urinary AGT reflects intrarenal RAS activity only.
Moreover, the exchangeable sodium should be assessed to
show sodium retention; however, this exceeded the scope of
our study.
In conclusion, the results of our study suggest that in children
with DM1, increased levels of uAGT may reflect early renal
involvement, before the onset of microalbuminuria. An increase
in uAGT precedes HTN, and may be considered as a new
marker of HTN in diabetic childrenwith normal urinary albumin
excretion. Decreased sodium excretion seems to be involved in
the development of HTN and early renal injury. Both uAGTand
uNa are associated with BP in normoalbuminuric diabetic
children.
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